Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3k, akt, c-src, and AP-1 signaling pathway

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Chen, Hsien Te ^a,b,c   Tsou, Hsi Kai ^c,d,e   Chang, Chia Hao ^f   Tang, Chih Hsin ^a,g  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c FENG CHIA UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^f Chang Hua Hospital   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CURCUMIN; LUCIFERASE; OSTEOPONTIN; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN KINASE P60; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL LINE; DRUG EFFECT; ENZYMOLOGY; METABOLISM;

CELL LINE; HEPATOCYTE GROWTH FACTOR; HUMANS; OSTEOBLASTS; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSCRIPTION FACTOR AP-1;

EID: 84861861110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038378     Document Type: Article

References (32)

1. van't Hof RJ, Ralston SH, (2001) Nitric oxide and bone. Immunology 103: 255-261.
2. Goltzman D, (2002) Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov 1: 784-796.
3. Ducy P, Schinke T, Karsenty G, (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289: 1501-1504.
4. Lane NE, Kelman A, (2003) A review of anabolic therapies for osteoporosis. Arthritis Res Ther 5: 214-222.
5. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS, (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. The Journal of clinical investigation 107: 1055-1061.
6. Wang KX, Denhardt DT, (2008) Osteopontin: role in immune regulation and stress responses. Cytokine & growth factor reviews 19: 333-345.
7. Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, et al. (2001) Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. The Journal of experimental medicine 193: 399-404.
8. Nakamura T, Nawa K, Ichihara A, (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochemical and biophysical research communications 122: 1450-1459.
9. Luetteke NC, Michalopoulos GK, (1985) Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells. Cancer research 45: 6331-6337.
10. Funakoshi H, Nakamura T, (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clinica chimica acta; international journal of clinical chemistry 327: 1-23.
11. Sengupta S, Gherardi E, Sellers LA, Wood JM, Sasisekharan R, et al. (2003) Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arteriosclerosis, thrombosis, and vascular biology 23: 69-75.
12. Montesano R, Matsumoto K, Nakamura T, Orci L, (1991) Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901-908.
13. Grano M, Galimi F, Zambonin G, Colucci S, Cottone E, et al. (1996) Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proceedings of the National Academy of Sciences of the United States of America 93: 7644-7648.
14. D'Ippolito G, Schiller PC, Perez-stable C, Balkan W, Roos BA, et al. (2002) Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 31: 269-275.
15. Hsieh MT, Hsieh CL, Lin LW, Wu CR, Huang GS, (2003) Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology. Life sciences 73: 1007-1016.
16. Wang YC, Lee PJ, Shih CM, Chen HY, Lee CC, et al. (2003) Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction. Analytical biochemistry 319: 206-215.
17. Huang HC, Shi GY, Jiang SJ, Shi CS, Wu CM, et al. (2003) Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. The Journal of biological chemistry 278: 46750-46759.
18. Tseng CP, Huang CL, Huang CH, Cheng JC, Stern A, et al. (2003) Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS letters 541: 21-27.
19. Chiu YC, Lin CY, Chen CP, Huang KC, Tong KM, et al. (2009) Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1- dependent pathway. J Immunol 183: 2785-2792.
20. Sharma P, Kumar S, Kundu GC, (2010) Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Molecular cancer 9: 178.
21. Mahtouk K, Tjin EP, Spaargaren M, Pals ST, (2010) The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas. Biochimica et biophysica acta 1806 208-219 pp. 208-219.
22. Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, et al. (2004) Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 279: 1359-1367.
23. Grotegut S, Kappler R, Tarimoradi S, Lehembre F, Christofori G, et al. (2010) Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation. International journal of oncology 36: 1261-1267.
24. Jin W, Yun C, Jeong J, Park Y, Lee HD, et al. (2008) c-Src is required for tropomyosin receptor kinase C (TrkC)-induced activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. The Journal of biological chemistry 283: 1391-1400.
25. Roskoski R Jr, (2005) Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331: 1-14.
26. Jiang WG, Hiscox S, (1997) Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles. Histology and histopathology 12: 537-555.
27. Taichman R, Reilly M, Verma R, Ehrenman K, Emerson S, (2001) Hepatocyte growth factor is secreted by osteoblasts and cooperatively permits the survival of haematopoietic progenitors. British journal of haematology 112: 438-448.
28. Buitenhuis M, (2011) The role of PI3K/protein kinase B (PKB/c-akt) in migration and homing of hematopoietic stem and progenitor cells. Current opinion in hematology 18: 226-230.
29. Qureshi HY, Ahmad R, Sylvester J, Zafarullah M, (2007) Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. Cell Signal 19: 1643-1651.
30. Yeh M, Gharavi NM, Choi J, Hsieh X, Reed E, et al. (2004) Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 279: 30175-30181.
31. Nakayama H, Nagai H, Matsumoto K, Oguro R, Sugimoto K, et al. (2011) Association between osteopontin promoter variants and diastolic dysfunction in hypertensive heart in the Japanese population. Hypertension research: official journal of the Japanese Society of Hypertension 34: 1141-1146.
32. Barizzone N, Marchini M, Cappiello F, Chiocchetti A, Orilieri E, et al. (2011) Association of osteopontin regulatory polymorphisms with systemic sclerosis. Human immunology 72: 930-934.